no statement of use filed
on 04 Jul 2022
Last Applicant/ Owned by
531 South Spring Street
Burlington
NC
27215
Serial Number
88581014 filed on 15th Aug 2019
Registration Number
N/A
Correspondent Address
William M. Bryner
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"HEALTH"
"HEALTH" Advisory services relating to regulatory compliance in the fields of pharmaceuticals and medical devices; monitoring of regulatory compliance in non-clinical and clinical pharmaceutical and medical device trials; investigation of assets, preparation and review of reports and assessments for regulatory purposes; providing information and advice regarding regulatory compliance; regulatory Read More
Advisory services relating to regulatory compliance in the fields of pharmaceuticals and medical devices; monitoring of regulatory compliance in non-clinical and clinical pharmaceutical and medical device trials; investigation of assets, preparation and review of reports and assessments for regulatory purposes; providing information and advice regarding regulatory compliance; regulatory compliance consulting in the fields of pharmaceuticals and medical devices; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical devices
Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; financial administration of patient reimbursement programs
Business consultancy, business management consultancy, business strategy advisory and marketing services for pharmaceutical, medical device, food and healthcare companies; business consulting services, business strategy advisory services and marketing services relating to the development, formulation and testing of pharmaceuticals, bio-technology products and medical devices; business consulting services, business strategy advisory services and marketing services relating to conducting of clinical trials; business consulting services, business strategy advisory services and marketing services relating to the commercialization of pharmaceutical products, bio-technological products or medical devices; business consulting services, business strategy advisory services and marketing services relating to lead candidate drug optimization; business organization consultancy; retail store and wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; personnel recruitment; business project management services in the fields of clinical and non-clinical programs, clinical and non-clinical drug development and research studies, clinical and non-clinical trials or proof of concept trials; business consultation in the nature of design and development of market access strategies; implementation of market access strategies and processes on behalf of others for business purposes; business data analysis and reporting, review and analysis of medical and clinical data for third parties and providing a report on the meaning of such data to third parties for business cost analysis; business consultation services in the market authorization of drugs; commercial administration of the licensing of the goods and services of others; compilation of information into computer databases; business advisory services, business consultancy services, business data analysis, business information services, business management consulting, business strategy services, market research, marketing services, database management, and business project management services, all in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; business management services, namely, supply and demand forecasting drug supplies for clinical trials; business management services, namely, recruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; Business services provided to the health care industry, namely, consulting services, market intelligence, data collection, data submission and patient management; holding company services, namely, providing ownership cost analyses, financial control audits, and business information reporting services for subsidiaries and affiliates; holding company services, namely, providing business management and business administration services for subsidiaries and affiliates
No 88581014
No Service Mark
No 1152090
Yes
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 05th Jul 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 04th Jul 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| 03rd Dec 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 01st Dec 2021 | SOU TEAS EXTENSION RECEIVED |
| 01st Dec 2021 | SOU EXTENSION 1 FILED |
| 01st Dec 2021 | SOU EXTENSION 1 GRANTED |
| 01st Jun 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 06th Apr 2021 | PUBLISHED FOR OPPOSITION |
| 06th Apr 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 17th Mar 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
